Methods of using splicing modulators
Abstract:
This disclosure relates to methods for the treatment of neoplastic disorders by administering Compound 1, or a pharmaceutically acceptably salt thereof, on its own and/or as part of a conjugate or composition, and inducing production of at least one neoantigen.
Public/Granted literature
Information query
Patent Agency Ranking
0/0